Role of central and peripheral tachykinin NK1 receptors in capsaicin-induced pain and hyperalgesia in mice

Pain

Volumn 90, Issue 1-2, 2001, Pages 97-103

  Laird, J M A ^a,d   Roza, C ^a   De Felipe, C ^b   Hunt, S P ^c   Cervero, F ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d Tel: +34 91 885 4595 ^*  (Spain)

Author keywords

NK1 receptor knockout mice; Plasma extravasation; Substance P

Indexed keywords

CAPSAICIN; NEUROKININ 1 RECEPTOR; SUBSTANCE P;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; EVOKED RESPONSE; EXTRAVASATION; HYPERALGESIA; LICKING; MALE; MECHANICAL STIMULATION; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR BLOCKING; SENSORY NERVE CELL;

ANIMALS; CAPSAICIN; HYPERALGESIA; INDOLES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PAIN MEASUREMENT; REACTION TIME; RECEPTORS, NEUROKININ-1;

EID: 0035252574     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(00)00394-8     Document Type: Article

References (29)

1. Neurogenic hyperalgesia: The search for the primary cutaneous afferent fibers that contribute to capsaicin-induced pain and hyperalgesia
2. Neurogenic amplification of immune complex inflammation
3. Primary afferent tachykinins are required to experience moderate to intense pain
4. A psychophysical study of secondary hyperalgesia: Evidence for increased pain to input from nociceptors
5. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P
6. Neurokinin 1 and 2 antagonists attenuate the responses and NK1 antagonists prevent the sensitization of primate spinothalamic tract neurons after intradermal capsaicin
7. Cutaneous stimuli releasing substance P in the dorsal horn of the cat
8. Enhanced withdrawal responses to heat and mechanical stimuli following intraplantar injection of capsaicin in rats
9. Spinal substance P receptor expression and internalization in acute, short-term and long-term inflammatory pain states
10. Nociceptor modulated central sensitization causes mechanical hyperalgesia in acute chemogenic and chronic neuropathic pain
11. Responsiveness and functional attributes of electrically localized terminals of cutaneous c-fibers in vivo and in vitro
12. Mechanical hyperalgesia evoked by intradermal capsaicin but not that evoked by partial nerve ligation is abolished in NK1 receptor knockout mice
13. Deficits in visceral pain and hyperalgesia of mice with a disruption of the tachykinin NK1 receptor gene
14. Neurogenic hyperalgesia: Psychophysical studies of underlying mechanisms
15. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin
16. Neurokinin-1 receptors are involved in behavioral responses to high-intensity heat stimuli and capsaicin-induced hyperalgesia in mice
17. Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation
18. Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor
19. Mechanically insensitive afferents (MIAs) in cutaneous nerves of monkey
20. Transmission of chronic nociception by spinal neurons expressing the substance P receptor
21. Differences in expression of oligosaccharides, neuropeptides, carbonic anhydrase and neurofilament in rat primary afferent neurons retrogradely labelled via skin, muscle or visceral nerves
22. 1 receptor. Part II: Distribution and pathophysiological roles
23. 1 receptor antagonists
24. 1 receptor antagonist L-733,060 in gerbils
25. The capsaicin test for evaluating tachykinin antagonists in the spinal cord
26. Antinociception induced by CP-96,345, a non-peptide NK-1 receptor antagonist, in the mouse formalin and capsaicin test
27. Encoding of burning pain from capsaicin-treated human skin in two categories of unmyelinated nerve fibres
28. Novel classes of responsive and unresponsive C nociceptors in human skin
29. Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets